1. IDF2022-0613 PIONEER 11: Efficacy and safety of oral semaglutide versus placebo in predominantly Chinese patients with T2D treated with diet and exercise. (March 2023) Authors: Wang, W.; Chen, R.; Davies, A. Lloyd; Guo, J.; Jensen, T. Bo; Li, Y.; Luo, B.; Ye, X.; Zhang, K.; Ning, G. Journal: Diabetes research and clinical practice Issue: Volume 197(2023)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗